| ALTIMMUNE INC. DL-,0001 |
| USA |
| Gesundheit |
| US02155H2004 / A2N5Z6 |
| 3G0 (Frankfurt) / ALT (NASDAQ) |
| FRA:3G0, ETR:3G0, 3G0:GR, NASDAQ:ALT |
| - |
| https://altimmune.com/ |
|
Altimmune, Inc. is a biopharmaceutical company eng..
>Volltext.. |
| 386.12 Mio. EUR |
| 219.79 Mio. EUR |
| 0.02 Mio. EUR |
| -78.11 Mio. EUR |
| -72.55 Mio. EUR |
| -0.92 EUR |
| 13.75 Mio. EUR |
| 52.98 Mio. EUR |
| -57.63 Mio. EUR |
| 16.72 |
| -63.51% |
| 23.09% |
| - |
| - |
| - |
| 20.01.17 - 224502.93€ |
| - |
| ALTIMMUNE |
| 12.11.25 |
|